Key structures of bacterial peptidoglycan and lipopolysaccharide triggering the innate immune system of higher animals: Chemical synthesis and functional studies

Proceedings of the Japan Academy Series B: Physical and Biological Sciences

Volumn 86, Issue 4, 2010, Pages 322-337

  Kusumoto, Shoichi ^a   Fukase, Koichi ^b   Shiba, Tetsuo ^c  

^a SUNTORY INSTITUTE FOR BIOORGANIC RESEARCH   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c Protein Research Foundation   (Japan)

Author keywords

Chemical synthesis; Innate immunity; Lipid A; Lipopolysaccharide; Muramyl peptides; Peptidoglycan

Indexed keywords

LIPID A; LIPOPOLYSACCHARIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINE; PEPTIDOGLYCAN;

ANIMAL; BACTERIUM; CHEMISTRY; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; REVIEW; SYNTHESIS;

ACETYLMURAMYL-ALANYL-ISOGLUTAMINE; ANIMALS; BACTERIA; HUMANS; IMMUNITY, INNATE; LIPID A; LIPOPOLYSACCHARIDES; PEPTIDOGLYCAN;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 77955114234     PISSN: 03862208     EISSN: 13492896     Source Type: Journal    
DOI: 10.2183/pjab.86.322     Document Type: Review

References (86)

1. Stewart-Tull, D. E. S. (1985) Immunopotentiating activity of peptidoglycan and surface polymers. In Immunology of Bacterial Cell Envelope (eds. Stewart-Tull, D. E. S. and Davies, M.). JohnWiley & Sons, Chichester, UK, pp. 47-89.
2. Rietschel, E. Th. and Westphal, O. (1999) Endotoxin: Historical perspectives. In Endotoxin in Health and Disease (eds. Brade, H., Opal, S. M., Vogel, S. N. and Morrison, D. C). Marcel Dekker, New York, pp. 1-31.
3. Kotani, S., Narita, T., Stewart-Tull, D. E. S., Shimono, T., Watanabe, Y., Kato, K. et al. (1975) Immunoadjuvant activities of cell walls and their water-soluble fractions prepared from gram-positive bacteria. Biken J. 18, 77-92.
4. Akira, S. (2009) Innate immunity to pathogens: diversity in receptors for microbial recognition. Immunol. Rev. 227, 5-8.
5. Ghuysen, J. M. and Hackenbeck, B. (1994) New Comprehensive Biochemistry. Elsevier Biomedical, Amsterdam.
6. Vollmer, W. and Born, P. (2009) Bacterial cell envelope peptidoglycan. In Microbial Glycobiology (ed. Moran, A. P). Academic Press, London, pp. 15-28.
7. Kotani, S., Watanabe, Y., Shimono, T., Narita, T., Kato, K., Stewart-Tull, D. E. S. et al. (1975) Immunoadjuvant activities of cell walls, their water-soluble fractions and peptidoglycan subunits, prepared from various gram-positive bacteria, and of synthetic N-acetylmuramyl peptides. Z. Immun.-Forsch. 149, 302-319.
8. Kusumoto, S., Tarumi, Y., Ikenaka, K. and Shiba, T. (1976) Chemical synthesis of N-acetylmuramyl peptides with partial structures of bacterial cell wall and their analogs in relation to immunoadjuvant activities. Bull. Chem. Soc. Jpn. 49, 533-539.
9. Ellouz, F., Adam, A., Ciorubaru, R. and Lederer, E. (1974) Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochim. Biophys. Res. Commun. 59, 1317-1325.
10. Merser, C., Sinay, P. and Adam, A. (1975) Total synthesis and adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 66, 1316-1322.
11. Kotani, S., Watanabe, Y., Kinoshita, F., Morisaki, I., Kato, K., Shiba, T. et al. (1977) The effect of replacement of L-alanine residue by glycine, L-serine or D-alanine in an N-acetylmuramyl-L-alanyl-D-isoglutamine on immunoadjuvancies of molecules. Biken J. 20, 39-45.
12. Kusumoto, S., Ikenaka, K. and Shiba, T. (1979) Syntheses of several muramyl peptides in relation to chemical structures of less immunoadjuvant bacterial cell walls. Bull. Chem. Soc. Jpn. 52, 1665-1671.
13. 14C]alanyl-D-isoglutamine via a novel synthetic route. Bull. Chem. Soc. Jpn. 52, 1177-1181.
14. Kusumoto, S., Yamamoto, K. and Shiba, T. (1978) Synthesis of N-acetyl-β-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine. Tetrahedron Lett. 19, 4407-4410.
15. Tsujimoto, M., Kinoshita, F., Okunaga, T., Kotani, S., Kusumoto, S., Yamamoto, K. et al. (1979) Higher immunoadjuvant activities of N-acetyl-β-D-glucosaminyl-(1-4)-N-acetylmuramyl-L-alanyl-D-isoglutamine in comparison with N-acetylmuramyl-L-alanyl-D-isoglutamine. Microbiol. Immumol. 23, 933-936.
16. Inamura, S., Fukase, K. and Kusumoto, S. (2001) Synthetic study of peptidoglycan partial structures. Synthesis of tetrasaccharide and octasaccharide fragments. Tetrahedron Lett. 42, 7613-7616.
17. Inamura, S., Fujimoto, Y., Kawasaki, A., Shiokawa, Z., Woelk, E., Heine, H. et al. (2006) Synthesis of peptidoglycan fragments and evaluation of their biological activity. Org. Biomol. Chem. 4, 232-242.
18. Weidemann, B. Schletter, J., Dziarski, R., Kusumoto, S., Stelter, F., Rietschel, E. Th. et al. (1997) Specific binding of soluble peptidoglycan and muramyl-dipeptide to CD14 on human monocytes. Infect. Immun. 65, 858-864.
19. Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J. et al. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. J. Biol. Chem. 278, 5509-5512.
20. Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L. et al. (2003) An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4, 652-654.
21. Kawasaki, A., Karasudani, Y., Otsuka, Y., Hasegawa, M., Inohara, N., Fujimoto, Y. et al. (2008) Synthesis of diaminopimelic acid containing peptidoglycan fragments and tracheal cytotoxin (TCT) and investigation of their biological functions. Chem. Eur. J. 14, 10318-10330.
22. Schleifer, K. H. and Kandler, O. (1972) Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev. 36, 407-477.
23. Inohara, N., Chmaillard, M., McDonald, C. and Nuñez, G. (2005) NOD-LRR proteins: Role in host-microbial interactions and inflammatory disease. Ann. Rev. Biochem. 74, 355-383.
24. Hasegawa, M., Yang, K., Hashimoto, M., Park, J.-H., Kim, Y.-G., Fujimoto, Y. et al. (2006) Differential release and distribution of Nod1 and Nod2 immunostimulatory molecules among bacterial species and environments. J. Biol. Chem. 281, 29054-29063.
25. Pfeiffer, R. Z. (1892) Untersuchengen über das Choleragift. Hygiene 11, 393-412.
26. Westphal, O., Lüderitz, O. and Bister, F. (1952) Überdie Extraction von Bakterien mit Phenol/Wasser. Z. Naturforsch. 7, 148-155.
27. Westphal, O. and Lüderitz, O. (1954) Chemische Erforschung von Lipopolysacchariden gram-negativer Bakterien. Angew. Chemie 66, 407-417.
28. Lüderitz, O., Galanos, C, Lehmann, V., Nurminen, M., Rietschel, E. Th., Rosenfelder, G. et al. (1973) Lipid A: Chemical structure and biological activity. J. Infect. Dis. 128 (Suppl.), 17-29.
29. Rietschel, E. Th., Sydorczyk, Z., Zähringer, U., Wollenweber, H.-W. and Lüderitz, O. (1983) Analysis of primary structure of lipid A. In Bacterial Lipopolysaccharide (eds. Anderson, L. and Unger, F. M.). ACS Symposium Series 231, American Chemical Society, Washington DC, pp. 195-218.
30. Inage, M., Chaki, H., Imoto, M., Shimamoto, T., Kusumoto, S. and Shiba, T. (1983) Synthetic approach to lipid A: Preparation of phosphorylated disaccharides containing ®-3-hydroxyacyl and ®-3-acyloxyacyl groups. Tetrahedron Lett. 24, 2011-2014.
31. Kusumoto, S., Inage, M., Chaki, H., Imoto, M., Shimamoto, T. and Shiba, T. (1983) Chemical synthesis of lipid A for the elucidation of structure-activity relationship. In Bacterial Lipopolysaccharide (eds. Anderson, L. and Unger, F. M.). ACS Symposium Series 231, American Chemical Society, Washington DC, pp. 237-254.
32. Lüderitz, O., Tanamoto, K., Galanos, C., Westphal, O., Zähringer, U., Rietschel, E. Th. et al. (1983) Structural principles of lipopolysaccharides and biological properties of synthetic partial structures. In Bacterial Lipopolysaccharide (eds. Anderson, L. and Unger, F. M.). ACS Symposium Series 231, American Chemical Society, Washington DC, pp. 3-17.
33. Imoto, M., Kusumoto, S., Shiba, T., Naoki, H., Iwashita, T., Rietschel, E. Th. et al. (1983) Chemical structure of E. coli lipid A: Linkage site of acyl groups in the disaccharide backbone. Tetrahedron Lett. 24, 4017-4020.
34. Imoto, M., Yoshimura, H., Kusumoto, S. and Shiba, T. (1984) Total synthesis of lipid A, active principle of bacterial endotoxin. Proc. Japan Acad., Ser. B 60, 285-288.
35. Imoto, M., Kusumoto, S., Shiba, T., Rietschel, E. Th., Galanos, C. and Lüderitz, O. (1985) Chemical structure of Escherichia coli lipid A. Tetrahedron Lett. 26, 907-908.
36. Imoto, M., Yoshimura, H., Yamamoto, M., Shimamoto, T., Kusumoto, S. and Shiba, T. (1984) Chemical synthesis of phosphorylated tetraacyl disaccharide corresponding to a biosynthetic precursor of lipid A. Tetrahedron Lett. 25, 2667-2670.
37. Imoto, M., Yoshimura, H., Yamamoto, M., Shimamoto, T., Kusumoto, S. and Shiba, T. (1987) Chemical synthesis of a biosynthetic precursor of lipid A with a phosphorylated tetraacyl disaccharide structure. Bull. Chem. Soc. Jpn. 60, 2197-2204.
38. Imoto, M., Yoshimura, H., Shimamoto, T., Sakaguchi, N., Kusumoto, S. and Shiba, T. (1987) Total synthesis of Escherichia coli lipid A, the endotoxically active principle of cell-surface lipopolysaccharide. Bull. Chem. Soc. Jpn. 60, 2205-2214.
39. Galanos, C., Lehman, V., Lüderitz, O., Rietschel, E. Th., Westphal, O., Brade, H. et al. (1984) Endotoxic properties of chemically synthesized lipid A part structures - comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A. Eur. J. Biochem. 140, 221-227.
40. Takada, H., Kotani, S., Tsujimoto, M., Ogawa, T., Takahashi, I., Harada, K. et al. (1985) Immunopharmacological activities of a synthetic counterpart of a biosynthetic lipid A precursor molecule and of its analogs. Infect. Immun. 48, 219-227.
41. Galanos, C, Lüderitz, O., Rietschel, E. Th., Westphal, O., Brade, H., Brade, L. et al. (1985) Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur. J. Biochem. 148, 1-5.
42. Kotani, S., Takada, H., Tsujimoto, M., Ogawa, T., Takahashi, I., Ikeda, T. et al. (1985) Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli Re-mutant. Infect. Immun. 49, 225-237.
43. Liu, W.-C, Oikawa, M., Fukase, K., Suda, Y. and Kusumoto, S. (1999) A divergent synthesis of lipid A and its chemically stable unnatural analogues. Bull. Chem. Soc. Jpn. 72, 1377-1385.
44. Takada, H. and Kotani, S. (1989) Structural requirements of lipid A for endotoxicity and other biological activities. CRC Critical Rev. Microbiol. 16, 477-523.
45. Takada, H. and Kotani, S. (1992) Structure-function relationships of lipid A. In Bacterial Endotoxic Lipopolysaccharides. Vol. I: Molecular Biochemistry and Cellular Biology (eds. Morrison, D. C. and Ryan, J. L.). CRC Press, Boca Raton, USA, pp. 43-65.
46. Kusumoto, S., Fukase, K., Fukase, Y., Kataoka, M., Yoshizaki, H., Sato, K. et al. (2003) Structural basis for endotoxic and antagonistic activities: investigation with novel synthetic lipid A analogs. J. Endotoxin Res. 9, 361-366.
47. Kusumoto, S., Fukase K. and Fujimoto, Y. (2007) Synthesis of lipopolysaccharide, peptidoglycan and lipoteichoic acid fragments. In Comprehensive Glycoscience. Vol. 1 (ed. Kamerling J. P.). Elsevier, Amsterdam, pp. 685-711.
48. Kusumoto, S., Fukase, K. and Fujimoto, Y. (2009) Chemical synthesis of bacterial lipid A. In Microbial Glycobiology, Structures, Relevance and Applications (ed. Moran, A. P.). Academic Press, London, pp. 415-427.
49. Kusumoto, S., Hashimoto, M. and Kawahara, K. (2009) Structure and synthesis of lipid A. In Lipid A in Cancer Therapy (ed. Jeaninn, J.-F.). Advances in Experimental Medicine and Biology. Vol. 667, Landes Bioscience, New York, pp. 5-23.
50. Flad, H.-D., Loppnow, H., Feist, W., Wang, M.-H., Brade, H., Kusumoto, S. et al. (1989) Interleukin 1 and tumor necrosis factor: Studies on the induction by lipopolysaccharide partial structures. Lymphokine Research 8, 235-238.
51. Wang, M.-H., Feist, W., Herzbeck, H., Brade, H., Kusumoto, S., Rietschel, E. Th. et al. (1990) Suppressive effect of lipid A partial structures on lipopolysaccaride or lipid A-induced release of interleukin 1 by human monocytes. FEMS Microbiol. Immunol. 64, 179-186.
52. Salimath, P. V., Weckesser, J., Strittmater, W. and Meyer, H. (1983) Structural studies on the nontoxic lipid A from Rhodopseudomonas sphaeroides ATCC 17023. Eur. J. Biochem. 136, 195-200.
53. Takayama, K., Qureshi, N., Beutler, B. and Kirkland, T. N. (1989) Diphosphoryl lipid A from Rhodopseudomonas sphaeroides ATCC 1702 blocks induction of cachectin in macrophage by lipopolysaccharide. Infect. Immun. 57, 1336-1338.
54. Christ, W. J., Asano, O., Robidoux, A. L., Perez, M., Wang, Y., Dubuc, G. R. et al. (1994) E5531, a pure endotoxin antagonist of high potency. Science 268, 80-83.
55. Rossignol, D. P., Hawkins, L. D., Christ, W. J., Kobayashi, S., Kawata, T., Lynn, M. et al. (1999) Synthetic endotoxin antagonist. In Endotoxin in Health and Disease (eds. Brade, H., Opal, S. M., Vogel, S. N. and Morrison, D. C). Marcel Dekker, New York, pp. 699-717.
56. Kusama, T., Soga, T., Shioya, E., Nakayama, K., Nakajima, H., Osada, Y. et al. (1990) Synthesis and antitumor activity of lipid A analogs having a phosphonooxyethyl group with α- or β-configuration at position 1. Chem. Pharm. Bull. 38, 3366-3372.
57. Kusama, T., Soga, T., Ono, Y., Kumazawa, E., Shioya, E., Osada, Y. et al. (1991) Synthesis and biological activities of analogs of a lipid A biosynthetic precursor: 1- O-phosphonooxyethyl-4'- O-phosphono-disaccharides with ®-3-hydroxytetradecanoyl or tetradecanoyl groups at positions 2, 3, 2' and 3'. Chem. Pharm. Bull. 39, 1994-1999.
58. Fukase, Y., Fujimoto, Y., Adachi, Y., Suda, Y., Kusumoto, S. and Fukase, K. (2008) Synthesis of Rubrivivax gelatinosus lipid A and analogues for investigation of the structural basis for immunostimulating and inhibitory activities. Bull. Chem. Soc. Jpn. 81, 796-819.
59. Sakai, Y., Oikawa, M., Yoshizaki, H., Ogawa, T., Suda, Y., Fukase, K. et al. (2000) Synthesis of Helicobacter pylori lipid A and its analogue using p-(trinuoromethyl)benzyl protecting group. Tetrahedron Lett. 41, 6843-6847.
60. Fukase, K., Fukase, Y., Oikawa, M., Liu, W.-C, Suda, Y. and Kusumoto, S. (1998) Divergent synthesis and biological activities of lipid A analogues of shorter acyl chains. Tetrahedron 54, 4033-4050.
61. Ulmer, A. J., Heine, H., Feist, W., Kusumoto, S., Kusama, T., Brade, H. et al. (1992) Biological-activity of synthetic phosphonooxyethyl analogs of lipid-A and lipid-A partial structures. Infect. Immun. 60, 3309-3314.
62. 3H]-labeled bioactive lipid A analogs and their use for detection of lipid A-binding proteins on murine macrophages. Bull. Chem. Soc. Jpn. 74, 2189-2197.
63. Zähringer, U., Lindner, B., Seydel, U., Rietschel, E. Th., Naoki, H., Unger, F. M. et al. (1985) Structure of de-O-acylated lipopolysaccharide from the Escherichia coli Re mutant strain F515. Tetrahedron Lett. 26, 6321-6324.
64. Yoshizaki, H., Fukuda, N., Sato, K., Oikawa, M., Fukase, K., Suda, Y. et al. (2001) First total synthesis of the Re-type lipopolysaccharide. Angew. Chem. Int. Ed. 40, 1475-1480.
65. Imoto, M., Kusunose, N., Matsuura, Y., Kusumoto, S. and Shiba, T. (1987) Preparaton of novel pyranosyl fluorides of 3-deoxy-D-manno-2-octulosonic acid (KDO) feasible for synthesis of KDO α-glycosides. Tetrahedron Lett. 28, 6277-6280.
66. Imoto, M., Kusumoto, S. and Shiba, T. (1987) A new synthesis of 3-deoxy-D- manno-2-octulosonic acid (KDO) from D-mannose. Tetrahedron Lett. 28, 6235-6238.
67. van der Klein, P. A. M., Boons, G. J. P. H., Veeneman, G. H., van der Marel, G. A. and van Boom, J. H. (1989) An efficient route to 3-deoxy-D-manno-2-octulosonic acid (KDO) derivatives via a 1,4-cyclic sulfate approach. Tetrahedron Lett. 30, 5477-5480.
68. Fukase, K., Kurosawa, M. and Kusumoto, S. (1994) Synthesis and purification by HPLC of des-O-acyl partial structures of Escherichia coli Re lipopolysaccharide. J. Endotoxin Res. 1, 149-163.
69. Fujimoto, Y., Iwata, M., Imakita, N., Shimoyama, A., Suda, Y., Kusumoto, S. et al. (2007) Synthesis of immunoregulatory Helicobacter pylori lipopolysaccharide partial structures. Tetrahedron Lett. 48, 6577-6581.
70. Ulevitch, R. J. and Tobias, P. S. (1995) Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu. Rev. Immunol. 13, 437-457.
71. Takeda, K. (2009) The lipid A receptor. In Lipid A in Cancer Therapy (ed. Jeaninn, J.-F.). Advances in Experimental Medicine and Biology. Vol. 667, Landes Bioscience, New York, pp. 53-58.
72. Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J. M. and Hoffmann, J. A. (1996) The drosoventral regulatory gene cassette spätzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell, 86, 973-983.
73. Akira, S. and Takeda, K. (2004) Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511.
74. Kumar, H., Kawai, T. and Akira, S. (2009) Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388, 621-625.
75. Lien, E., Means, T. K., Heine, H., Yoshimura, A., Kusumoto, S., Fukase, K. et al. (2000) Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clinic. Invest. 105, 497-504.
76. Shimazu, R., Akashi, S., Ogata, Y., Nagai, Y., Fukudome, K., Miyake, K. et al. (1999) MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777-1782.
77. Saitoh, S.-I., Akashi, S., Yamada, T., Tanimura, N., Kobayashi, M., Konno, K. et al. (2004) Lipid A antagonist, lipid lVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization. Int. Immunol. 16, 961-969.
78. Kobayashi, M., Saitoh, S., Tanimura, N., Takahashi, K., Kawasaki, K., Nishijima, M. et al. (2006) Regulatory roles for MD-2 and TLR4 in ligand-induced receptor clustering. J. Immunol. 176, 6211-6218.
79. Saitoh, S.-I. and Miyake, K. (2006) Mechanism regulating cell surface expression and activation of Tolllike receptor 4. The Chemical Record 6, 311-319.
80. Ohto, U., Fukase, K., Miyake, K. and Satow, Y. (2007) Crystal structures of human MD-2 and its complex with antiendotoxic lipid IVa. Science 316, 1632-1634.
81. Kim, H. M., Park, B. S., Kim, J.-I., Kim, S. E., Lee, J., Oh, S. C. et al. (2007) Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 130, 906-917.
82. Park, B. S., Song, D. H., Kim, H. M., Choi, B. S., Lee, H. and Lee, J. O. (2009) The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature 458, 1191-1195.
83. Seydel, U., Wiese, A., Schromm, A. B. and Brandenburg, K. (1999) A biophysical view on the function and activity of endotoxins. In Endotoxin in Health and Disease (eds. Brade, H., Opal, S. M., Vogel, S. N. and Morrison, D. C.). Marcel Dekker, New York, pp. 195-219.
84. 31P-NMR spectroscopic and microscopic investigations. Biophysical J. 95, 1226-1238.
85. Nomura, K., Maeda, M., Sugase, K. and Kusumoto, S. (2010) Lipopolysaccharide induces raft domain expansion in membrane composed of a phospholipid-cholesterol-sphingomyelin ternary system. Innate Immun. 16, in press and references cited therein.
86. Sasaki, N., Ogasawara, M., Sekiguchi, T., Kusumoto, S. and Satake, H. (2009) Toll-like receptors of the ascidian Ciona intestinalis. Protoypes with hybrid functionalities of vertebrate Toll-like receptors. J. Biol. Chem. 284, 27336-27343 and references cited therein.